Literature DB >> 22946521

The natural history of cognitive decline in Alzheimer's disease.

Robert S Wilson1, Eisuke Segawa, Patricia A Boyle, Sophia E Anagnos, Loren P Hizel, David A Bennett.   

Abstract

The study aim was to describe the temporal course of cognitive decline in Alzheimer's disease (AD). We selected 226 persons from 2 longitudinal clinical-pathological studies who were cognitively healthy at baseline, followed at least 4 years (M = 10.2, SD = 3.5), and clinically diagnosed with AD at some point during follow-up. Each evaluation included a battery of 17 cognitive tests from which a previously established composite measure of global cognition was derived. In those who died, a uniform neuropathologic examination established the pathological diagnoses of Alzheimer's disease and other common conditions that impair cognition. Mixed-effects models with 2 change points were used to assess trajectories of cognitive decline. In the main analysis, there was no change in cognitive function until a mean of 7.5 years before dementia was diagnosed (95% confidence interval [CI]: -8.3, -6.7). The global cognitive measure declined a mean of 0.087-unit per year (95% CI: -0.099, -0.073) until a mean of 2.0 years before the diagnosis (95% CI: -2.2, -1.7) when it increased more than 4-fold to a mean loss of 0.370-unit per year (95% CI: -0.417, -0.334). Of 126 individuals who died and underwent autopsy, 101 (80%) met pathologic criteria for AD, of whom 67 had at least one other pathologic condition. Pathologic measures of AD and cerebral infarction were not strongly related to cognitive trajectories. The results indicate that cognitive decline in AD begins many years before dementia is diagnosed and accelerates during the course of the disease. 2013 APA, all rights reserved

Entities:  

Mesh:

Year:  2012        PMID: 22946521      PMCID: PMC3534850          DOI: 10.1037/a0029857

Source DB:  PubMed          Journal:  Psychol Aging        ISSN: 0882-7974


  43 in total

1.  Neurodegenerative basis of age-related cognitive decline.

Authors:  R S Wilson; S E Leurgans; P A Boyle; J A Schneider; D A Bennett
Journal:  Neurology       Date:  2010-09-15       Impact factor: 9.910

2.  The BUGS project: Evolution, critique and future directions.

Authors:  David Lunn; David Spiegelhalter; Andrew Thomas; Nicky Best
Journal:  Stat Med       Date:  2009-11-10       Impact factor: 2.373

3.  Heterogeneity of cognitive trajectories in diverse older persons.

Authors:  Dan Mungas; Laurel Beckett; Danielle Harvey; Sarah Tomaszewski Farias; Bruce Reed; Owen Carmichael; John Olichney; Joshua Miller; Charles DeCarli
Journal:  Psychol Aging       Date:  2010-09

4.  Lewy bodies and olfactory dysfunction in old age.

Authors:  Robert S Wilson; Lei Yu; Julie A Schneider; Steven E Arnold; Aron S Buchman; David A Bennett
Journal:  Chem Senses       Date:  2011-01-21       Impact factor: 3.160

5.  Cognitive decline in prodromal Alzheimer disease and mild cognitive impairment.

Authors:  Robert S Wilson; Sue E Leurgans; Patricia A Boyle; David A Bennett
Journal:  Arch Neurol       Date:  2011-03

6.  Cognitive decline in incident Alzheimer disease in a community population.

Authors:  R S Wilson; N T Aggarwal; L L Barnes; C F Mendes de Leon; L E Hebert; D A Evans
Journal:  Neurology       Date:  2010-03-23       Impact factor: 9.910

7.  Loss of basic lexical knowledge in old age.

Authors:  Robert S Wilson; Kristin R Krueger; Patricia A Boyle; David A Bennett
Journal:  J Neurol Neurosurg Psychiatry       Date:  2010-08-27       Impact factor: 10.154

8.  Terminal dedifferentiation of cognitive abilities.

Authors:  R S Wilson; E Segawa; L P Hizel; P A Boyle; D A Bennett
Journal:  Neurology       Date:  2012-04-04       Impact factor: 9.910

9.  Biracial population study of mortality in mild cognitive impairment and Alzheimer disease.

Authors:  Robert S Wilson; Neelum T Aggarwal; Lisa L Barnes; Julia L Bienias; Carlos F Mendes de Leon; Denis A Evans
Journal:  Arch Neurol       Date:  2009-06

10.  The neuropathology of probable Alzheimer disease and mild cognitive impairment.

Authors:  Julie A Schneider; Zoe Arvanitakis; Sue E Leurgans; David A Bennett
Journal:  Ann Neurol       Date:  2009-08       Impact factor: 10.422

View more
  76 in total

Review 1.  Redox proteomics and amyloid β-peptide: insights into Alzheimer disease.

Authors:  D Allan Butterfield; Debra Boyd-Kimball
Journal:  J Neurochem       Date:  2018-11-27       Impact factor: 5.372

2.  A Cognitive Turning Point in Development of Clinical Alzheimer's Disease Dementia and Mild Cognitive Impairment: A Biracial Population Study.

Authors:  Kumar B Rajan; Robert S Wilson; Lisa L Barnes; Neelum T Aggarwal; Jennifer Weuve; Denis A Evans
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2017-03-01       Impact factor: 6.053

3.  Effect of common neuropathologies on progression of late life cognitive impairment.

Authors:  Lei Yu; Patricia A Boyle; Sue Leurgans; Julie A Schneider; Richard J Kryscio; Robert S Wilson; David A Bennett
Journal:  Neurobiol Aging       Date:  2015-04-22       Impact factor: 4.673

4.  Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

Authors:  Willam T Wang; Breeya A Tailor; David S Cohen; Xudong Huang
Journal:  EC Pharmacol Toxicol       Date:  2019-06-21

5.  The Economic Value of Informal Caregiving for Persons With Dementia: Results From 38 States, the District of Columbia, and Puerto Rico, 2015 and 2016 BRFSS.

Authors:  Kristina M Rabarison; Erin D Bouldin; Connie L Bish; Lisa C McGuire; Christopher A Taylor; Kurt J Greenlund
Journal:  Am J Public Health       Date:  2018-08-23       Impact factor: 9.308

6.  Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

Authors:  Marie-Hélène Pilon; Stéphane Poulin; Marie-Pierre Fortin; Michèle Houde; Louis Verret; Rémi W Bouchard; Robert Laforce
Journal:  Neurology (ECronicon)       Date:  2016-03-11

7.  Cognitive Trajectory Changes Over 20 Years Before Dementia Diagnosis: A Large Cohort Study.

Authors:  Ge Li; Eric B Larson; Jane B Shofer; Paul K Crane; Laura E Gibbons; Wayne McCormick; James D Bowen; Mary Lou Thompson
Journal:  J Am Geriatr Soc       Date:  2017-09-21       Impact factor: 5.562

Review 8.  Stem cell therapies in age-related neurodegenerative diseases and stroke.

Authors:  Yuan Wang; Xunming Ji; Rehana K Leak; Fenghua Chen; Guodong Cao
Journal:  Ageing Res Rev       Date:  2016-11-19       Impact factor: 10.895

9.  Longitudinal trajectories of everyday function by diagnostic status.

Authors:  Sarah Tomaszewski Farias; Elizabeth Chou; Danielle J Harvey; Dan Mungas; Bruce Reed; Charles DeCarli; Lovingly Quitania Park; Laurel Beckett
Journal:  Psychol Aging       Date:  2013-12

10.  Harm avoidance and cerebral infarction.

Authors:  Robert S Wilson; Patricia A Boyle; Steven R Levine; Lei Yu; George M Hoganson; Aron S Buchman; Julie A Schneider; David A Bennett
Journal:  Neuropsychology       Date:  2013-12-23       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.